Portfolio company
Adaptive Biotechnologies
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company provides immune-sequencing tests and research services for clinicians, biopharmaceutical firms and academic researchers to diagnose, monitor and treat diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Cofactor Genomics
This company develops RNA-based diagnostic tests and predictive immune modelling to help healthcare providers and pharmaceutical researchers identify patient responses to immunotherapy.
Veracyte
This company develops genomic tests and diagnostic tools to help clinicians and patients make informed treatment decisions for various types of cancer.
Foundation Medicine
This company develops genomic profiling tests to help doctors and researchers identify treatment options for cancer patients.
Motley Bio
This company develops multi-omic sequencing technology for disease detection and drug discovery services for biotechnology and pharmaceutical firms.
Biotia
This company develops genomic sequencing software and diagnostic tests to identify infectious diseases for hospitals, researchers and patients.
Prometheus Biosciences
This biotechnology company develops precision medicine therapies and companion diagnostic tests for patients with inflammatory bowel disease and other immune-mediated conditions.
Foresight Diagnostics
This company develops liquid biopsy tests to detect minimal residual disease in cancer patients for biopharmaceutical companies and healthcare providers.
10X Genomics
This company develops instruments, consumables and software for single-cell and spatial biology research, serving academic institutions and biopharmaceutical firms.
